1Fett DL,Gibson LE,SU WP. Sweet's syndrome:systemic signs and symptoms and associated disorders. Mayo Clin Proc,1995, 70:234-240.
2Ai-Saad K, Khanani MF, Naqvi A, et al. Sweet' s syndrome developing during treatment with all-trans retinoic acid in a child with acute myelogenous leukemia. J Pedlar Hematol Oncol, 2004,26:197- 199.
3Cohen PR, Talpaz M, Kurzrock R. Malignancy-associated Sweet' s syndrome.- review of the world literature. J Chn Oncol, 1988, 6:1887-1897.
4Cohen PR, Kurzrock R. Sweet's syndrome:a neutrophilic dermatosis classically associated with acute onset and fever. Clin Dermatol, 2000,18 : 265-282.
5Cohen PR,Kurzrock R. Sweet's syndrome revisitedt a review of disease concepts. Int J Dermatol,2003, 42:761-778.
6Giasuddin ASM,Ei-Orfi AHA,Ziu MM,et al. Sweet's syndrome is the pathogenesis mediated by helper T cell type 1 eytokine? J Am Acad Dermatol, 1998,39:940-943.
7Fukutoku M, Shmizu SK,Ogawa Y, et al. Sweet's syndrome duing the rapywith granulocyte colony-stimulating factor in a patient with aplastic anaema. Br J Haematol, 1994,86:645.
8Park JW, Mehrotra B, Barnett BD, et at. The Sweet's syndrome during therapy with granulocyte eoloy stimulating factor. Am Inter Med,1992,116:996-998.
